Toggle light / dark theme

AI Designed Peptides Could Cure… EVERYTHING. LigandForge Is Here

LigandForge generates 150,000 peptide drug candidates in 3 minutes — a million times faster than existing methods, unlocking a tsunami of possible treatments.

A man with no medical background used ChatGPT, AlphaFold, and Grok to design a custom mRNA cancer vaccine for his dying dog — and her biggest tumor shrank 75%.

Meanwhile, scientists discovered a single protein that literally spreads aging through your bloodstream. These stories are each incredible on their own. But the big story is the implications for curing aging.

In this deep dive, I break down how these three breakthroughs fit together, what peptides and mRNA vaccines actually are (and how they’re different), and why this moment might be the most important inflection point in the history of drug design.

The age of custom AI cures isn’t coming. It’s here.

HUME BODY POD DISCOUNT UP TO 50% OFF:
Code: EMMETT
https://humehealth.com/pages/hume-bod… TIMESTAMPS 0:00 — Cold Open 2:50 — Intro 2:59 — HUME AD 4:14 — The Dog That Changed Everything 6:59 — The Peptide Warp Drive 10:00 — The Biohacker Connection 12:16 — The Aging Signal in Your Blood 14:28 — Connecting the Dots 15:42 — What’s Next 🔗 SOURCES & LINKS Paul Conyngham & Rosie — CBS News Interview: https://www.cbsnews.com/video/ai-expe… Paul Conyngham & Rosie — NBC News Interview (Gadi Schwartz): https://www.nbcnews.com/video/austral… UNSW News — “Meet the Man Who Designed a Cancer Vaccine for His Dog”: https://news.unsw.edu.au/en/meet-the–… LigandForge Preprint — Single-Pass Discrete Diffusion (bioRxiv): https://www.biorxiv.org/content/10.64… Andre Watson (@nanogenomic) — LigandForge Announcement: https://twitter.com/nanogenomic/status/2034… Anish Moonka — LigandForge Breakdown Thread: https://twitter.com/AnishA_Moonka/status/20… Antonio Linares — “Peptides Are the Tip of the Iceberg” Thread: https://twitter.com/alc2022/status/20349621… Dr. Ashley Froese — “Doctor Reviews Peptides — Changing Medicine Forever”: • Doctor Reviews Peptides — Changing Medicin… HMGB1 Aging Study — Metabolism Journal (PubMed): https://pubmed.ncbi.nlm.nih.gov/40189… HBP08 Peptide Inhibitor Study — Journal of Medicinal Chemistry (PubMed): https://pubmed.ncbi.nlm.nih.gov/34510… UNSW RNA Institute: https://www.unsw.edu.au/institutes/rna Amino Asylum (Gray Market Peptide Vendor): https://aminoasylums.net/ JAMA Study — Median Cost of Bringing a Drug to Market ($985M): https://jamanetwork.com/journals/jama… David Baker Nobel Prize in Chemistry 2024: https://www.nobelprize.org/prizes/che… ⚠️ Disclaimer: This video is for educational and informational purposes only and does not constitute medical advice. Consult a qualified clinician before making health or treatment decisions. 🔗 EXCLUSIVE INTERVIEWS & BONUS CONTENT Get extended conversations, deep dives, and behind-the-scenes research as a YouTube Member Patreon: 👉 / u29506604 YT Membership: 👉 / @longevitysciencenews PRODUCTION CREDITS ⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺⎺ Executive Producer – Keith Comito ‪@Retromancers‬ Host, Producer, Writer – Emmett Short ‪@emmettshort‬ 🔬 TOPICS COVERED AI drug discovery, peptide design, LigandForge, AlphaFold, ChatGPT, Grok, mRNA vaccine, personalized medicine, custom cancer vaccine, Paul Conyngham, Rosie, dog cancer vaccine, mast cell cancer, c-KIT mutation, UNSW RNA Institute, Pall Thordarson, Andre Watson, Ligandal, discrete diffusion model, BoltzGen, BindCraft, RFdiffusion, David Baker, Nobel Prize Chemistry 2024, protein design, protein folding, computational biology, HMGB1, ReHMGB1, senescent cells, senescence, SASP, cellular aging, parabiosis, young blood, aging signal, Ok Hee Jeon, Korea University, NF-κB, JAK/STAT, semaglutide, Ozempic, Wegovy, GLP-1, peptide therapeutics, biohacking, BPC-157, TB-500, PT-141, gray market peptides, TNF-alpha, PD-L1, VEGF-A, HER2, Humira, Tecentriq, Herceptin, proteome, amino acids, longevity, anti-aging, regenerative medicine, DIY medicine, biotech.

Read more

Leave a Comment

Lifeboat Foundation respects your privacy! Your email address will not be published.

/* */